Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Comparison of Molecular and Histologic Ultrastaging Methods in Sentinel Lymph Node Analysis from Clinical Stage II Colon Cancers.

Deroo O, Lakkis Z, Paquette B, Grand D, Monnien F, Felix S, Borg C, Heyd B, Kim S, Valmary-Degano S.

Appl Immunohistochem Mol Morphol. 2019 Aug;27(7):e65-e70. doi: 10.1097/PAI.0000000000000624.

PMID:
31393285
2.

["Discovering Pathology", a serious game dedicated to the discovery of pathology for medical students].

Jacquier A, Briot M, Barillot G, Deroo O, Monnien F, Hurlot Q, Frenois FX, Aubin F, Degano B, Reffay C, Valmary-Degano S.

Ann Pathol. 2019 Apr;39(2):151-157. doi: 10.1016/j.annpat.2018.12.002. Epub 2019 Jan 28. French.

PMID:
30704896
3.

ATG9A Is Overexpressed in Triple Negative Breast Cancer and Its In Vitro Extinction Leads to the Inhibition of Pro-Cancer Phenotypes.

Claude-Taupin A, Fonderflick L, Gauthier T, Mansi L, Pallandre JR, Borg C, Perez V, Monnien F, Algros MP, Vigneron M, Adami P, Delage-Mourroux R, Peixoto P, Herfs M, Boyer-Guittaut M, Hervouet E.

Cells. 2018 Dec 6;7(12). pii: E248. doi: 10.3390/cells7120248.

4.

Down-regulation of A-FABP predicts non-muscle invasive bladder cancer progression: investigation with a long term clinical follow-up.

Mathis C, Lascombe I, Monnien F, Bittard H, Kleinclauss F, Bedgedjian I, Fauconnet S, Valmary-Degano S.

BMC Cancer. 2018 Dec 10;18(1):1239. doi: 10.1186/s12885-018-5137-4.

5.

A dualistic model of primary anal canal adenocarcinoma with distinct cellular origins, etiologies, inflammatory microenvironments and mutational signatures: implications for personalised medicine.

Herfs M, Roncarati P, Koopmansch B, Peulen O, Bruyere D, Lebeau A, Hendrick E, Hubert P, Poncin A, Penny W, Piazzon N, Monnien F, Guenat D, Mougin C, Prétet JL, Vuitton L, Segers K, Lambert F, Bours V, de Leval L, Valmary-Degano S, Quick CM, Crum CP, Delvenne P.

Br J Cancer. 2018 May;118(10):1302-1312. doi: 10.1038/s41416-018-0049-2. Epub 2018 Apr 27.

6.

Pediatric Chordomas: Results of a Multicentric Study of 40 Children and Proposal for a Histopathological Prognostic Grading System and New Therapeutic Strategies.

Beccaria K, Tauziède-Espariat A, Monnien F, Adle-Biassette H, Masliah-Planchon J, Pierron G, Maillot L, Polivka M, Laquerrière A, Bouillot-Eimer S, Gimbert E, Gauchotte G, Coffinet L, Sevestre H, Alapetite C, Bolle S, Thompson D, Bouazza S, George B, Zérah M, Sainte-Rose C, Puget S, Varlet P.

J Neuropathol Exp Neurol. 2018 Mar 1;77(3):207-215. doi: 10.1093/jnen/nlx118. Erratum in: J Neuropathol Exp Neurol. 2018 Aug 1;77(8):747.

PMID:
29361006
7.

Immunohistochemical evaluation of two antibodies against PD-L1 and prognostic significance of PD-L1 expression in epithelioid peritoneal malignant mesothelioma: A RENAPE study.

Valmary-Degano S, Colpart P, Villeneuve L, Monnien F, M'Hamdi L, Lang Averous G, Capovilla M, Bibeau F, Laverriere MH, Verriele-Beurrier V, Ben Rejeb H, Dartigues P, Hommell-Fontaine J, Gilly FN, Isaac S, Mery E; French RENAPE Network.

Eur J Surg Oncol. 2017 Oct;43(10):1915-1923. doi: 10.1016/j.ejso.2017.05.009. Epub 2017 May 18.

PMID:
28619621
8.

Loss of SMARCE1 expression is a specific diagnostic marker of clear cell meningioma: a comprehensive immunophenotypical and molecular analysis.

Tauziede-Espariat A, Parfait B, Besnard A, Lacombe J, Pallud J, Tazi S, Puget S, Lot G, Terris B, Cohen J, Vidaud M, Figarella-Branger D, Monnien F, Polivka M, Adle-Biassette H, Varlet P.

Brain Pathol. 2018 Jul;28(4):466-474. doi: 10.1111/bpa.12524. Epub 2017 Jun 12.

PMID:
28474749
9.

Somatic mutational spectrum analysis in a prospective series of 104 gastrointestinal stromal tumors.

Guenat D, Deroo O, Magnin S, Chaigneau L, Monnien F, Borg C, Mougin C, Emile JF, Prétet JL.

Oncol Rep. 2017 Mar;37(3):1671-1681. doi: 10.3892/or.2017.5384. Epub 2017 Jan 17.

PMID:
28098915
10.

Human papillomaviruses in colorectal cancers: A case-control study in western patients.

Vuitton L, Jaillet C, Jacquin E, Monnien F, Heberle M, Mihai MI, Lassabe C, Raffoul J, Puyraveau M, Lakkis Z, Lamfichekh N, Picard A, Prétet JL, Mougin C, Valmary-Degano S.

Dig Liver Dis. 2017 Apr;49(4):446-450. doi: 10.1016/j.dld.2016.11.003. Epub 2016 Nov 14.

PMID:
27931969
11.

[Authorization of pathologists for the estimation of the tumor cell percentage on tissue sample for molecular analysis purpose].

Luquain A, Arbez-Gindre F, Bedgedjian I, Felix S, Harimenshi JM, Mihai IM, Monnien F, Singeorzan C, Valmary-Degano S.

Ann Pathol. 2016 Aug;36(4):268-74. doi: 10.1016/j.annpat.2016.06.004. Epub 2016 Jul 26. French.

PMID:
27474532
12.

Prognostic and Therapeutic Markers in Chordomas: A Study of 287 Tumors.

Tauziéde-Espariat A, Bresson D, Polivka M, Bouazza S, Labrousse F, Aronica E, Pretet JL, Projetti F, Herman P, Salle H, Monnien F, Valmary-Degano S, Laquerrière A, Pocard M, Chaigneau L, Isambert N, Aubriot-Lorton MH, Feuvret L, George B, Froelich S, Adle-Biassette H.

J Neuropathol Exp Neurol. 2016 Feb;75(2):111-20.

PMID:
26733585
13.

The autophagy GABARAPL1 gene is epigenetically regulated in breast cancer models.

Hervouet E, Claude-Taupin A, Gauthier T, Perez V, Fraichard A, Adami P, Despouy G, Monnien F, Algros MP, Jouvenot M, Delage-Mourroux R, Boyer-Guittaut M.

BMC Cancer. 2015 Oct 17;15:729. doi: 10.1186/s12885-015-1761-4.

14.

Prognostic value of angiopoietin-2 for death risk stratification in patients with metastatic colorectal carcinoma.

Jary M, Vernerey D, Lecomte T, Dobi E, Ghiringhelli F, Monnien F, Godet Y, Kim S, Bouché O, Fratte S, Gonçalves A, Leger J, Queiroz L, Adotevi O, Bonnetain F, Borg C.

Cancer Epidemiol Biomarkers Prev. 2015 Mar;24(3):603-12. doi: 10.1158/1055-9965.EPI-14-1059. Epub 2015 Jan 12.

15.

Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapy.

Fiteni F, Jary M, Monnien F, Nguyen T, Beohou E, Demarchi M, Dobi E, Fein F, Cleau D, Fratté S, Nerich V, Bonnetain F, Pivot X, Borg C, Kim S.

BMC Gastroenterol. 2014 Aug 13;14:143. doi: 10.1186/1471-230X-14-143.

16.

Bifractionated CPT-11 with LV5FU2 infusion (FOLFIRI-3) in combination with bevacizumab: clinical outcomes in first-line metastatic colorectal cancers according to plasma angiopoietin-2 levels.

Kim S, Dobi E, Jary M, Monnien F, Curtit E, Nguyen T, Lakkis Z, Heyd B, Fratte S, Cléau D, Lamfichekh N, Nerich V, Guiu B, Demarchi M, Borg C.

BMC Cancer. 2013 Dec 27;13:611. doi: 10.1186/1471-2407-13-611.

17.

Signature patterns of human papillomavirus type 16 in invasive anal carcinoma.

Valmary-Degano S, Jacquin E, Prétet JL, Monnien F, Girardo B, Arbez-Gindre F, Joly M, Bosset JF, Kantelip B, Mougin C.

Hum Pathol. 2013 Jun;44(6):992-1002. doi: 10.1016/j.humpath.2012.08.019. Epub 2012 Dec 23.

PMID:
23266444
18.

Impact of STAT3 phosphorylation on the clinical effectiveness of anti-EGFR-based therapy in patients with metastatic colorectal cancer.

Dobi E, Monnien F, Kim S, Ivanaj A, N'Guyen T, Demarchi M, Adotevi O, Thierry-Vuillemin A, Jary M, Kantelip B, Pivot X, Godet Y, Degano SV, Borg C.

Clin Colorectal Cancer. 2013 Mar;12(1):28-36. doi: 10.1016/j.clcc.2012.09.002. Epub 2012 Oct 17.

PMID:
23083634
19.

Specific skin lesions in chronic myelomonocytic leukemia: a spectrum of myelomonocytic and dendritic cell proliferations: a study of 42 cases.

Vitte F, Fabiani B, Bénet C, Dalac S, Balme B, Delattre C, Vergier B, Beylot-Barry M, Vignon-Pennamen D, Ortonne N, Algros MP, Carlotti A, Samaleire D, Frouin E, Levy A, Laroche L, Theate I, Monnien F, Mugneret F, Petrella T.

Am J Surg Pathol. 2012 Sep;36(9):1302-16.

PMID:
22895265
20.

Prognostic value of phosphorylated STAT3 in advanced rectal cancer: a study from 104 French patients included in the EORTC 22921 trial.

Monnien F, Zaki H, Borg C, Mougin C, Bosset JF, Mercier M, Arbez-Gindre F, Kantelip B.

J Clin Pathol. 2010 Oct;63(10):873-8. doi: 10.1136/jcp.2010.076414.

PMID:
20876317
21.

Expression analysis of VEGF-A and VEGF-B: relationship with clinicopathological parameters in bladder cancer.

Fauconnet S, Bernardini S, Lascombe I, Boiteux G, Clairotte A, Monnien F, Chabannes E, Bittard H.

Oncol Rep. 2009 Jun;21(6):1495-504.

PMID:
19424629
22.

The expression of Twist has an impact on survival in human bladder cancer and is influenced by the smoking status.

Fondrevelle ME, Kantelip B, Reiter RE, Chopin DK, Thiery JP, Monnien F, Bittard H, Wallerand H.

Urol Oncol. 2009 May-Jun;27(3):268-76. doi: 10.1016/j.urolonc.2007.12.012. Epub 2008 Apr 28.

PMID:
18440840

Supplemental Content

Loading ...
Support Center